drugset / Trial / NCT05699005

Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMO

NCT05699005

RandomizedParallel-groupDouble-blindTreatment

Summary

This multicenter randomized controlled trial compare two transfusion strategies of red blood cells transfusion in patients supported by veno-arterial extracorporeal membrane oxygenation for refractory cardiogenic shock. An individualized transfusion strategy based on ScVO2 level, is compared to a conventionnal strategy based on predefined hemoglobin threshold. The primary endpoint is the consumption of packed red blod cells, secondary endpoints are subgroup analysis, mortality, morbidity, and cost-effectiveness

Timeline

Start
2023-09-18
Primary completion
2028-03-18
Completion
2028-12-18

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Packed Red Blood Cells Unknown